ArticleCancers2021

Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study.

Marta Tenuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.